„Improving accessibility and comprehension of informed consent documents for clinical trial participants“: Informed consent is key to ethical clinical research. The increasing complexity and length of informed consent documents (ICDs) is a major concern. In fact, in our recent pilot study, we looked at ICDs for phase III drug trials across Europe and found that are highly variable in length, ranging from just 5 pages to up to 45 pages. In this workshop we will assess the needs of various stakeholders that work with ICDs and produce a list of key barriers and potential opportunities. By collaborative design we will develop a simplified template and practical guidance for tailoring ICDs. We see this workshop as a chance to help introducing a change in how we do informed consent — to make it more respectful, and truly understandable for everyone involved.
